High CVSS 7.4
CVE-2026-67558
NVD analysis in progress
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
What this means
- Exposure
- Exploitable from the adjacent network and without authentication — but only if a user opens booby-trapped content.
- Impact
- An attacker can read sensitive data and alter some data. The impact spreads beyond the vulnerable component into other parts of the system.
- Weakness
- Authentication relies on a spoofable value such as an IP address or header.
- Likelihood
- Its EPSS score stays low: nothing points to imminent exploitation, which is no reason to leave it unpatched.
What to doFold into the next patch cycle.
Read automatically from the CVSS vector, the weakness type (CWE) and the EPSS score. The technical description above remains the one published by NIST.